Form D · Biotechnology
Medicovestor, Inc.
New York, NY · CIK 0002099357
Offering snapshot reported Dec 5, 2025 · SEC filing
- Reported sold
- $3.16M Offering amount: $4.06M
- Investors reported
- 60 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 5, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 5, 2025 | Initial | $3,164,834 | No comparison | 60 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-565979
Simple Agreements for Future Equity
Source: Form D, filed Dec 5, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| William Clementi | Director |
| Seah Hooi Lim | Director, Executive |
| Chit Loh | Director |
| Farrah Ofner | Director |
| Lin Hu Ong | Director, Executive |
| Keung Wah Ken Tang | Executive |
| Benjamin Peter Behrang Vali | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
17 State Street 40 Th Floor
New York, NY, 10004
New York, NY, 10004